discoidal pre-β HDL particles The investigational medicinal product is given by intravenous infusions of 8 mg/kg at biweekly intervals NCT01412034 [208] TAUSSIG: a multicenter, open-label study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback